Jane Henderson, Director at Akero Therapeutics, Inc. (AKRO), sold 3,000 shares at $47.46 ($142K) on 2025-08-12, disclosed to the SEC on 2025-08-12.
Open-market sale of $142k AKRO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| APGE | SELL | 2026-04-03 | $170K | — | Filing → |
| APGE | SELL | 2026-03-27 | $170K | — | Filing → |
| APGE | SELL | 2026-03-04 | $140K | — | Filing → |